Bladder tuberculosis after BCG therapy.
The initial treatment of bladder cancer is transurethral resection (TUR), but this cancer recurs at an important rate, and has 14% chance of progression after TUR alone. Intravesical chemotherapy with Bacillus Calmette-Guerin (BCG) is effective against recurrence and progression of bladder cancer. However, this therapeutic expose to many local and systemic side-effects. We report a case of 63-year-old man who presented bladder tuberculosis after a BCG therapy, which required 6 months of antitubercular therapy.
Bouhabel
A
A
Department of Nephrology, Constantine Military Hospital, Algeria. ihab_bouhbel@yahoo.fr
Takoucht
F
F
Bousbia
W
W
Hamada
B
B
Lemaiaci
N
N
D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014376:Tuberculosis / Q000276:immunology*; D001745:Urinary Bladder Diseases / Q000276:immunology* / Q000382:microbiology*
D001500:BCG Vaccine